Efficacy and Safety of Rezum System Water Vapor Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia

Dixon Christopher; Cedano Edwin Rijo; Pacik Dalibor; Vit Viteslav; Varga Gabriel; Wagrell Lennart; Tornblom Magnus; Mynderse Lance; Larson Thayne

首页> 外文期刊>Urology >Efficacy and Safety of Rezum System Water Vapor Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia

【24h】

Efficacy and Safety of Rezum System Water Vapor Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia

机译：Rezum系统水蒸气处理对前列腺增生继发的下尿路症状的疗效和安全性

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

OBJECTIVE To assess 1-year efficacy and safety data from pilot trials of the Rezum System water vapor to treat lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH).

机译：目的评估Rezum系统水蒸气治疗良性前列腺增生（BPH）引起的下尿路症状（LUTS）的中试试验的1年疗效和安全性数据。

著录项

来源
《Urology》 |2015年第5期|共6页
作者
Dixon Christopher; Cedano Edwin Rijo; Pacik Dalibor; Vit Viteslav; Varga Gabriel; Wagrell Lennart; Tornblom Magnus; Mynderse Lance; Larson Thayne;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Efficacy and Safety of Rezum System Water Vapor Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia [J] . Dixon Christopher, Cedano Edwin Rijo, Pacik Dalibor, Urology . 2015,第5期

机译：Rezum系统水蒸气处理对前列腺增生继发的下尿路症状的疗效和安全性
2. Rezum Water Vapor Thermal Therapy for Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia: 4-Year Results From Randomized Controlled Study [J] . McVary Kevin T., Rogers Tyson, Roehrborn Claus G. Urology . 2019,第期

机译：Rezum水蒸气热疗，用于低尿路症状与良性前列腺增生相关：随机对照研究的4年结果
3. Re: rezum Water Vapor Thermal Therapy for Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia: 4-Year Results from Randomized Controlled Study [J] . Kaplan Steven A. The Journal of Urology . 2019,第1期

机译：Re：Rezum水蒸气热疗，用于低尿路症状与良性前列腺增生：随机对照研究的4年结果
4. Analysis of glycoforms of urinary prostate-specific antigen of prostate cancer and benign prostate hyperplasia samples [C] . Chun-Jen Hsiao, Tzong-Shin Tzai, Chein-Hung Chen, ASMS Conference on Mass Spectrometry and Allied Topics . 2015

机译：前列腺癌和良性前列腺增生样品的尿道前列腺特异性抗原糖族分析
5. The long-term cost-effectiveness of treatments for benign prostatic hyperplasia. [D] . DiSantostefano, Rachael Lynn. 2005

机译：良性前列腺增生治疗的长期成本效益。
6. Defining the Efficacy and Safety of Phosphodiesterase Type 5 Inhibitors with Tamsulosin for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia with or without Erectile Dysfunction: A Network Meta-Analysis [O] . Chengquan Ma, Jianzhong Zhang, Zhonglin Cai, 2020

机译：用坦索罗辛定义磷酸二酯酶5型抑制剂治疗伴或不伴勃起功能障碍的良性前列腺增生引起的下尿路症状的功效和安全性：网络荟萃分析
7. Defining the Efficacy and Safety of Phosphodiesterase Type 5 Inhibitors with Tamsulosin for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia with or without Erectile Dysfunction: A Network Meta-Analysis [O] . Chengquan Ma, Jianzhong Zhang, Zhonglin Cai, 2020

机译：定义磷酸二磷酸酯蛋白酶型5抑制剂的疗效和安全性，用于治疗患有或不带勃起功能障碍的良性前列腺增生的下泌尿道症状：网络元分析

Efficacy and Safety of Rezum System Water Vapor Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia

摘要

著录项

相似文献

相关主题

期刊订阅